Artwork

Contenido proporcionado por BioTalent Canada. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BioTalent Canada o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Commercializing the Academic Research – and Managing Substantial Growth

36:46
 
Compartir
 

Manage episode 360963687 series 3398740
Contenido proporcionado por BioTalent Canada. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BioTalent Canada o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that.

Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model is working, with growth forecast to see 60 staff currently blossom to 150 in the next 18 months.

In addition, the Government of Canada recently made an $80.5 million investment in a key project API is involved in.

But that success itself brings many challenges. How is API handling those?

Guest: Andrew MacIsaac, CEO Applied Pharmaceutical Innovation (API)

Website: appliedpharma.ca

LinkedIn: https://www.linkedin.com/company/applied-pharmaceutical-innovation

Twitter: @api_applied

BioTalent Canada Website

See the latest news on our website

Contact

BioTalent Canada by email

  continue reading

12 episodios

Artwork
iconCompartir
 
Manage episode 360963687 series 3398740
Contenido proporcionado por BioTalent Canada. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BioTalent Canada o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Applied Pharmaceutical Innovation (API) was launched to solve a big challenge. Commercialization within the life sciences. There’s a general lack of understanding of the technical and scientific capacity needed for a life sciences company to commercialize in Canada. API sought to fix that.

Part incubator, part R&D, API helps companies scale up here in Canada where they would normally have to invest tens of millions of dollars just to build out their infrastructure. And the model is working, with growth forecast to see 60 staff currently blossom to 150 in the next 18 months.

In addition, the Government of Canada recently made an $80.5 million investment in a key project API is involved in.

But that success itself brings many challenges. How is API handling those?

Guest: Andrew MacIsaac, CEO Applied Pharmaceutical Innovation (API)

Website: appliedpharma.ca

LinkedIn: https://www.linkedin.com/company/applied-pharmaceutical-innovation

Twitter: @api_applied

BioTalent Canada Website

See the latest news on our website

Contact

BioTalent Canada by email

  continue reading

12 episodios

Todos los episodios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida